Introduction
============

The UVB-driven conversion of cholesta-5, 7-diene-3β-ol (7-dehydrocholesterol, 7DHC) to (3β, 5Z, 7E)-9, 10-secocholesta-5, 7, 10(19)-trien-3-ol (cholecalciferol, vitamin D3) is one of the most fundamental reactions in photobiology.[@R1]^-^[@R3] In addition to vitamin D3, the reaction also generates tachysterol (6E-9, 10-secocholesta-5(10), 6, 8-trien-3β-ol, T), lumisterol (9β, 10α-cholesta-5, 7-diene-3β-ol, L), as well as iso-tachysterol. The conversion of 7DHC to its analogs has been demonstrated by the Holick group as a two-step process ([Fig. 1](#F1){ref-type="fig"}).[@R1] The first step is the formation of pre-D (unless specified, the term "D" used in this paper refer to the D3-like, D2-like, or pD analogs with short chains). The second step is the conversion of pre-D to the D, T, and L analogs. Tremendous efforts have been made to investigate the photosynthesis and biological activity of many D analogs with different side chains on the 17-position.[@R4]^-^[@R12] The effect of potential interactions of previtamin D3 with intracellular proteins and/or lipids in the skin on the kinetics and thermodynamics of the thermal isomerization to form vitamin D3 has been established.[@R2]^,^[@R13]^-^[@R15] However, to the best of our knowledge, the effects of the sidechain length and composition on the real time conversion kinetics from pre-D to D have not been reported in the literature.

![**Figure 1.** UVB induced transformation of 5,7-dienes to the D, T, and L-like analogs.](de-5-142-g1){#F1}

To determine the kinetics of the conversion of pre-D to D and to search for additional biologically active 5,7-dienes, a series of pregna-5, 7-dienes with different side chains were synthesized and subjected to UVB irradiation. The conversion from pre-D to D after UV initiation was monitored in real time by proton NMR at 37°C inside the NMR magnet. In addition, the distribution of each product from the UVB irradiation of novel 5,7-dienes synthesized was also described in this report to provide potential insights in optimizing yields of future organic synthesis for desired secosteroids and minimize undesired side products.

Results and Discussion
======================

Longer chain and the presence of a tertiary alcohol moiety on the side chain facilitate the conversion from pre-D to D
----------------------------------------------------------------------------------------------------------------------

The kinetics of the conversion from pre-D to D is shown in [Figure 2](#F2){ref-type="fig"} using compound **4a-S** as an example. Before irradiation, only proton NMR peaks corresponding to the 5,7-diene were observed (peaks 2 and 6, [Figure 2A](#F2){ref-type="fig"}). After UVB irradiation for 5 min, many new peaks appeared corresponding to different initial photolysis products ([Fig. 2B](#F2){ref-type="fig"}). Intensities of proton NMR peaks (peak number 5, 9 and 10, [Figure 2B and C](#F2){ref-type="fig"}) corresponding to pre-D decreased over time, while intensities of peaks (peak number 1,12,13, [Figure 2B and C](#F2){ref-type="fig"}) corresponding to D increased over time, clearly indicating that the thermodynamically unstable pre-D isomerized to the more stable D structure. There were no changes in the amounts for all other products (T, isoT, and L) based on the peak intensities corresponding to those products once UVB irradiation was terminated. [Figure 2D](#F2){ref-type="fig"} shows the real-time monitoring of changes of pre-D and D over time at 40 time points (30 min/time point). The rate of conversion was calculated by fitting the corresponding peaks at those time points. Results for all compounds are summarized in [Table 1](#T1){ref-type="table"}.

![**Figure 2.** 1.8 mM of each compound solution in methanol-d~4~ was irradiated for 5 min by UVB (280--315 nm). Each irradiated sample was monitored by proton NMR at 37°C immediately after the irradiation in a time course manner. Data was recorded for each time point of 0 min, 10 min, and every 30 min thereafter.](de-5-142-g2){#F2}

###### **Table 1.** Relative rates of conversion for the irradiated products (pre-D-like to D-like)

![](de-5-142-t1)

Relative rates of conversion for the irradiated products (pre-D-like to D-like) based on the slope (a) of the equation: Y = aX+b; Solvent: CD~3~OD; Concentration: 1.8 mMol. Temperature: 37°C; monitoring the changes by NMR every 30 min.

Analysis of the compound structures and their relative conversion rate reveal two interesting trends associated with side chain length and composition. First, with a few exceptions, compounds with a longer (or larger) side chain (e.g., **7cc**, **7cb**, **7cd**, **8a**) generally have a faster conversion rate than compounds with a shorter (or smaller) side chain (e.g., **4a-S**, **4c**, **4a-R**, **5c** and **4b**). Second, all compounds having a tertiary alcohol moiety at the C20 position (e.g., the top four ranked compounds **7cc**, **7cb**, **7ca**, and **7cd**) have higher conversion rate than those not having this tertiary alcohol moiety. This may suggest that pre-D compounds with tertiary alcohol side chains are more prone to undergo isomerization to form D analogs, therefore leading to the higher conversion rate than the non-tertiary moieties. [Figure 3](#F3){ref-type="fig"} shows the comparison of changes of D-like analogs over time using compounds **4a-R**, **8a**, and **7cc** as examples. Overall, compound **7cc** has the highest conversion rate while compound **4a-S** showed the lowest conversion rate.

![**Figure 3.** Comparison of conversion from pre-D analogs to D-like analogs over time for **4a-R**, **8a**, and **7cc**.](de-5-142-g3){#F3}

These results are somewhat unexpected. The isomerization of pre-D to form D is an antarafacial \[1,7\]-sigmatropic hydrogen shift from C19 to C9,[@R16]^,^[@R17] one of processes defined by the Woodward-Hoffmann rule.[@R18] This process requires a large rotation around C6-C7 bond which intuitively means a pre-D analog with a larger sidechain (e.g., **7cc**) may convert to the D analog slower than an analog with a shorter sidechain (e.g., **4a**). This seems to contradict to what we observed in this study. However, several previous report have shown that addition of a single hydroxyl group either on the sidechain (e.g., 25-hydroxylation[@R14]) or on the ring systems (e.g., 11-hydroxylation[@R19]) can significantly affect the kinetics of this conversion process. Since most of the analogs reported in the current study have a hydroxyl group at C20, it is possible that 20-hydroxylation also exerts its influence to the overall kinetics. It may also be worthwhile to point out that the only reaction observed in this process (proton NMR monitoring after irradiation) is the conversion of pre-D to D analogs. The characteristic peaks for D kept increasing over time while the characteristic peaks for pre-D kept decreasing. Proton NMR peaks corresponding to other molecules in the solution remains unchanged. This observation is consistent with the fact that the conversion from pre-D to D is a thermodynamic process, while the conversion from the 5,7-diene precursors to pre-D and from pre-D to tachysterol, lumisterol and iso-T is a photochemical process which requires UVB irradiation.

Effects of side chains on the 5,7-dienes on their photochemical product distributions
-------------------------------------------------------------------------------------

The distribution of the products after 5.5 h post UVB irradiation is shown in [Table 2](#T2){ref-type="table"}. We selected the 5.5 h as the ending point because after this time the kinetic curves from pre-D analogs to D analogs have significant deviation from linearity, although after a long time (5\~7 d), virtually all pre-D analogs are converted to their corresponding D analogs. As we discussed earlier, except D and pre-D, the amounts of other products from UVB irradiation of the 5,7-dienes remains unchanged during the proton NMR monitoring process. The percentage of the parent compounds is generally reversely proportional to the relative conversion rate, although there are some exceptions. This can be confirmed by **4a-S**, which had the lowest conversion rate but with the highest percentage of its parent compound (30%). Compounds with the highest conversion rates (**7cc**, **7cb**, **7ca** ranked 1st, 2nd, and 3rd, respectively) had relatively lower percentages of their parent compounds (15%, 14%, 10% for **7cc**, **7cb**, **7ca**, respectively). Compounds **4b**, **5c** had both low percentages of their parent compounds (17%, 9% for **4b**, **5c**, respectively) and low conversion rates (**4b**, **5c** ranked 9th, 10th, respectively). There does not appear to have an identifiable correlations between photochemical product distributions and the length or composition of the side chains in these 5,7-dienes, suggesting these two factors are not the dominant in this photochemical process. Percentages of lumisterol-like (L-like) and iso-tachesterol-like (iso-T-like) compounds are similar for all tested compounds (4--9% and 6--11% for L-like and iso-T-like compounds, respectively). It should be of particular interest to note that several compounds tend to form more T-like compounds (48%, 30%, 35%, 43%, 37% for **7cc**, **7cb**, **7ca**, **4b**, **5c**, respectively) during photolysis. This may suggest that the side chain of these molecules may accelerate the conversion of pre-D to T-like compounds. On the other hand, it might be attributed to the high stability of the T-like analogs of these compounds under UVB irradiation. The fact that compound **8a** had only 1% of T-like remaining but with a relatively higher amount of iso-T (11%) may indicate that the T-like analog of **8a** is extremely unstable in the presence of UVB irradiation and converted to the corresponding iso-T analog very quickly.

###### **Table 2.** Distribution of products 5.5 h after irradiation

![](de-5-142-t2)

Distribution of products 5.5 h after irradiation. The characteristic peak of each specific product (D, T, and L) was integrated 5.5h and divided by the sum of integrations of all products. NA, not available; D, Vitamin D; L, Lumisterol; T, Tachysterol; Pre-D, Pre-vitamin D; iso-T, iso-Tachysterol.

Even though no obvious correlation between the side chain and product distribution can be identified at this stage, these studies do suggest that they have certain influences on the product distribution. Accumulating evidence in the literature clearly indicated that unique nonhypercalcemic D analogs possessing beneficial biological activities (e.g., antiproliferation and anti-inflammation) exist either endogenously produced or newly synthesized.[@R4]^-^[@R7]^,^[@R9]^,^[@R12]^,^[@R20]^-^[@R32] Such compounds likely have significantly improved toxicity profiles compared with 1,25-dihydroxy vitamin D3 (the biologically active form of D3). At least currently, making these compounds using the classical photochemistry method[@R10]^,^[@R12] is much easier than total organic synthesis.[@R33]^-^[@R35] Therefore, understanding and proper use of the effects of the side chain and other factors on the photochemical product distributions may provide very useful controls when optimizing the yields of desired products while minimizing the undesired side products.

Conclusion
==========

We have synthesized several novel 5,7-dienes and examined the real-time conversion kinetics from pre-D analogs to their corresponding D analogs. The rate of this conversion was found to be correlated with side chain length and composition. Photochemical product distributions from these 5,7-dienes are also documented under the experimental conditions, although no significant correlations to the side chain was observed. To the best of our knowledge this is the first time that the kinetics for conversion in real time from pre-D to D is described. We are well aware the limitation of our current study performed in an isotropic solution environment that is too simple compared with the complex biological environment existing in the human skin. The interactions between pre-vitamin D3 and the surrounding biological environment have profound effects to the kinetics and thermodynamics of vitamin D3 formation.[@R2]^,^[@R13]^-^[@R15] Therefore, the future direction of this study will be to evaluate this thermal isomerization process of pre-D to D under a more physiologically relevant condition by using either human skin or its mimic such as a liposomal model.[@R13]^,^[@R14] Nevertheless, the current study could still serve as step-stones for future kinetic studies of novel 5,7-dienes under more physiologically relevant ex vivo or in vivo conditions, as well as providing insights in controlling yields of the biologically active products such as nonhypercalcemic D analogs from the photochemical transformation of novel 5,7-dienes.

Materials and Methods
=====================

Compound **8a** (7DHC) was purchased from Sigma-Aldrich and recrystallized from methanol to remove impurities. Compound **8b** (ergosterol) was also purchased from Sigma-Aldrich and used for NMR experiment without further purification. The synthesis of other compounds is outlined in [Figure 4](#F4){ref-type="fig"}. Compounds **4a-c**, **5c, 7cc, 6d** and **6da** were generated following a previously reported procedure.[@R7]^,^[@R8]^,^[@R11]^,^[@R12] Generally, compound **1** was protected by an acetyl group at the 3-position to give compound **2**. Compound **2** was then brominated at the 7-position followed by dehydrobromination to afford compound **3** with an extra double bond at the 7 position. Compound **3** was used for the generation of the subsequent products under various conditions. Compounds **7ca, 7cb, and 7cd** are new molecules that have not been reported previously. The synthesis of **7ca-cd** was performed by reacting **3c** with appropriate alky lithium or Grignard reagents to build up the tertiary alcohol moiety in the structure ([Fig. 4](#F4){ref-type="fig"}).[@R36]^-^[@R38] Alkyl lithium reagents for the synthesis of **7ca** and **7cd** were commercially available from Sigma-Aldrich. Grignard reagents used for the synthesis of **7cb** and **7cc** were freshly prepared by reacting the corresponding alkyl bromide with magnesium in anhydrous THF.[@R39] NMR and Mass spec data: **20-OH-20-Methyl-7DHP (7ca):** ^1^H NMR (500 MHz, CD~3~OD): δ 5.55--5.58 (m, 1 H), 5.39--5.42 (m, 1 H), 3.49--3.57 (m, 1 H), 2.40--2.46 (m, 1 H), 2.20--2.31 (m, 2 H), 1.31--2.01 (m, 24 H), 1.30 (s, 3 H), 1.23 (s, 3 H), 0.97 (s, 3 H), 0.80 (s, 3 H). ESI-MS: calculated for C~22~H~34~O~2~, 330.3, found 353.3 \[M+Na\]^+^. **20-OH-20-Hexyl-7DHP (7cb):** ^1^H NMR (500 MHz, CD~3~OD): δ 5.54--5.59 (m, 1 H), 5.38--5.42 (m, 1 H), 3.48--3.57 (m, 1 H), 2.40--2.47 (m, 1 H), 2.25--2.30 (m, 1 H), 2.16--2.25 (m, 1 H), 1.30--2.00 (m, 24 H), 1.28 (s, 3 H), 0.97 (s, 3 H), 0.93 (t, ***J*** = 6.0 Hz, 3 H), 0.82 (s, 3 H). ESI-MS: calculated for C~27~H~44~O~3~, 400.3, found 423.3 \[M+Na\]^+^. **20-OH-20-Phenyl-7DHP (7cd):** ^1^H NMR (500 MHz, CD~3~OD): δ 7.46 (d, ***J*** = 8.0 Hz, 2 H), 7.29 (t, ***J*** = 8.0 Hz, 2 H), 7.18 (t, ***J*** = 7.5 Hz, 1 H), 5.53--5.56 (m, 1 H), 5.35--5.39 (m, 1 H), 3.49--3.56 (m, 1 H), 2.39--2.45 (m, 1 H), 2.22--2.30 (m, 1 H), 1.68--2.06 (m, 8 H), 1.66 (s, 3 H), 1.25--1.65 (m, 7 H), 0.96 (s, 3 H), 0.83 (s, 3 H). ESI-MS: calculated for C~27~H~36~O~2~, 392.3, found 415.3 \[M+Na\]^+^. The synthesis and chromatographic data for **7cc**,[@R12] **6d**,[@R11] **6da**,[@R11] **4b**,[@R8] **4c**,[@R8] **5c**,[@R8] **4a-R**,[@R7] **4a-S**[@R7] were described in our previous publications.

![**Figure 4.** Synthesis of 5,7-dienes. Step a is for **1a**, **1d** only; step d is for **3(a--c)** only; step 3 is for **3c** only; step f is for **3d** only; step g is for **3c** only. Reagents and conditions: (**a**) Ac~2~O, microwave, p-toluenesulfonic acid monohydrate; (**b**) dibromantin, 2,2\'-azobisisobutyronitrile, benzene/hexane (1:1), 100°C, reflux; (**c**) Bu~4~NBr, Bu~4~NF, THF, rt; (**d**) LiAlH~4~, THF, 0°C; (**e**) K~2~CO~3~, MeOH-THF, Argon bubbling, rt; (**f**) K~2~CO~3~, MeOH-THF, air, rt; (**g**) R-Li (**7ca,7cd**) or R-MgBr (**7cb-mL**), THF; (**h**) DBU, THF, MeI.](de-5-142-g4){#F4}

Each of these compounds was dissolved in methanol-d~4~ to make a 1.8 mM solution and subsequently transferred to a quartz NMR tube. A standard proton NMR at 37þC was run for each sample before irradiation by UVB. Each sample was then irradiated for 5 min using a Biorad UV Transilluminator 2000 (Biorad, Hercules, CA). The spectral characteristics of the UVB (280--320 nm) source were published previously[@R40] and its strength (4.8 ± 0.2 mW cm^−1^) was measured routinely using a digital UVB Meter Model 6.0 (Solartech Inc., Harrison Twp,MI). Each irradiated sample was monitored by proton NMR at 37°C immediately after the irradiation in a time course manner. Data was recorded for each time point of 0 min, 10 min, and every 30 min thereafter. Analysis of data was accomplished by using ACD software (Advanced Chemistry Development, Toronto, ON, Canada). The percentage of products (D, T, L, iso-T) at each time point is determined by the peak areas calculated from the proton NMR spectra. The characteristic peak of each specific product (D, T, and L) was integrated at each time point and plotted against time to produce a kinetic curve (supporting information). The equation generated from this curve is expressed as follows: Y = *a*X+*b*, where *a* stands for the slope, *b* stands for the intercept of the curve in Y-axis. The slope *a* of the curve was taken as the relative conversion rate. The relative accuracy of the equation is judged by R^2^ (The closer to 1, the better).
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NMR

:   Nuclear Magnetic Resonance

UVB

:   Ultra-Violet B

7DHC

:   7-Dehydrocholesterol

7DHP

:   7-Dehydropregnenolone

D

:   Vitamin D (D3, D2, and pD for short chains)

T

:   Tachysterol

L

:   Lumisterol

Iso-T

:   iso-Tachysterol

RT

:   room temperature

THF

:   Tetrahydrofuran

DBU

:   Diazabicycloundecene
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